Search About Business Model Pipeline News Careers Contact path { stroke:#cacaca; stroke-width:.5 } .cycler-clipee { transition: opacity 1.597s linear; } THE LEADER IN GLOBALIZING CHINA’S BIOPHARMA INNOVATION HUYABIO Spotlight Meeting the challenge of unmet medical needs, a word from HUYABIO President & CEO Dr. Mireille Gillings LEARN MORE The Global Advantage HUYABIO International's world-class commercial scientific expertise LEARN MORE HUYABIO is the leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective and lower-risk drug development in the global markets. Through extensive collaboration with biopharmaceutical, academic and commercial organizations, it has built the largest China-sourced compound portfolio covering all therapeutic areas. With offices in the US, Japan, South Korea, Canada, Ireland and eight strategic locations across China, the Company has become a partner of choice to accelerate product development and maximize value globally. Copyright © 2021 HUYA Bioscience International, LLC. All rights reserved. HUYABIO™, HUYABIO International™ and HUYA Bioscience International® are among the trademarks of HUYA Bioscience International, LLC or its affiliates in the United States and/or other countries. | Terms of Use | Privacy Policy | Governance

Search About Business Model Pipeline News Careers Contact Welcome from the President & CEO HUYABIO Team Advisory Board Innovative R&D in life sciences is gaining momentum in the East with China leading the charge. This is the foundation of my vision for HUYABIO International. I wanted to identify and add value to the wealth of therapeutic opportunities from Chinese institutes and universities. HUYABIO has now grown to be the leader in globalizing China’s pharmaceutical innovation. Meeting the challenge of tomorrow’s unmet medical needs requires utilizing the talents of Chinese researchers and helping to move their discoveries forward. Our HUYABIO teams in San Diego, Tokyo, Dublin, Montreal, Seoul and our eight China offices are committed to building relationships that enable candidate compounds to be more accessible internationally. With diverse approaches including in-licensing, alliances, co-development, research funding and creative financial partnerships, HUYABIO is poised to bring China’s healthcare discoveries to benefit the rest of the world. Mireille Gillings, PhD, Hon DSc Copyright © 2021 HUYA Bioscience International, LLC. All rights reserved. HUYABIO™, HUYABIO International™ and HUYA Bioscience International® are among the trademarks of HUYA Bioscience International, LLC or its affiliates in the United States and/or other countries. | Terms of Use | Privacy Policy | Governance